Kennedy Bond
Vice President, Clinical Development – Neurodegenerative Diseases
Remote (US-based)
We are partnering with a pioneering biopharmaceutical company at the forefront of neurodegenerative disease research. Focused on delivering life-changing therapies for patients living with Alzheimer’s, Parkinson’s, ALS, and other CNS disorders, the company leverages precision medicine, biomarkers, and patient-centric strategies to tackle significant unmet medical needs.
The Role We are seeking an accomplished
Vice President, Clinical Development (Neurodegenerative Diseases)
to lead the strategic direction, design, and execution of the company’s neurodegenerative portfolio. This senior leadership role will be critical in advancing programs from early clinical development through regulatory submission and commercialization, working cross-functionally to deliver meaningful impact for patients.
Key Responsibilities Provide strategic and scientific leadership across all clinical development programs within the neurodegenerative disease portfolio. Design, oversee, and execute Phase I–IV clinical trials, ensuring scientific rigor, operational excellence, and compliance with global regulatory standards. Partner with regulatory affairs, translational science, and medical affairs to implement integrated clinical strategies that align with corporate objectives. Build, mentor, and lead a high-performing global clinical development team committed to innovation, collaboration, and scientific excellence. Cultivate strong relationships with neurologists, neurodegenerative disease KOLs, academic institutions, and patient advocacy groups. Stay up to date on advances in neuroscience, biomarkers, digital health endpoints, and disease-modifying therapies to inform clinical strategy.
About You MD or MD/PhD (or equivalent) with board certification in Neurology. 12+ years of progressive experience in clinical development, with deep expertise in neurodegenerative disorders. Proven track record of advancing neurodegenerative programs through key regulatory milestones (IND, NDA/BLA) and global submissions. Strong understanding of neurodegenerative trial design, clinical endpoints (cognitive, functional, biomarker), and biomarker strategies. Demonstrated leadership, strategic thinking, and ability to collaborate across functions and geographies. Passion for transforming the lives of patients affected by neurodegenerative diseases through innovation and clinical excellence.
Please contact:
Melissa Mallison | m.mallison@kennedybond.com
We are partnering with a pioneering biopharmaceutical company at the forefront of neurodegenerative disease research. Focused on delivering life-changing therapies for patients living with Alzheimer’s, Parkinson’s, ALS, and other CNS disorders, the company leverages precision medicine, biomarkers, and patient-centric strategies to tackle significant unmet medical needs.
The Role We are seeking an accomplished
Vice President, Clinical Development (Neurodegenerative Diseases)
to lead the strategic direction, design, and execution of the company’s neurodegenerative portfolio. This senior leadership role will be critical in advancing programs from early clinical development through regulatory submission and commercialization, working cross-functionally to deliver meaningful impact for patients.
Key Responsibilities Provide strategic and scientific leadership across all clinical development programs within the neurodegenerative disease portfolio. Design, oversee, and execute Phase I–IV clinical trials, ensuring scientific rigor, operational excellence, and compliance with global regulatory standards. Partner with regulatory affairs, translational science, and medical affairs to implement integrated clinical strategies that align with corporate objectives. Build, mentor, and lead a high-performing global clinical development team committed to innovation, collaboration, and scientific excellence. Cultivate strong relationships with neurologists, neurodegenerative disease KOLs, academic institutions, and patient advocacy groups. Stay up to date on advances in neuroscience, biomarkers, digital health endpoints, and disease-modifying therapies to inform clinical strategy.
About You MD or MD/PhD (or equivalent) with board certification in Neurology. 12+ years of progressive experience in clinical development, with deep expertise in neurodegenerative disorders. Proven track record of advancing neurodegenerative programs through key regulatory milestones (IND, NDA/BLA) and global submissions. Strong understanding of neurodegenerative trial design, clinical endpoints (cognitive, functional, biomarker), and biomarker strategies. Demonstrated leadership, strategic thinking, and ability to collaborate across functions and geographies. Passion for transforming the lives of patients affected by neurodegenerative diseases through innovation and clinical excellence.
Please contact:
Melissa Mallison | m.mallison@kennedybond.com